SOUTH SAN FRANCISCO, Calif., Oct. 3 /PRNewswire/ -- Solazyme, a
bioscience company pioneering biofuels and health/wellness products from
microalgae, has named Troy J. Campione, Ph.D., to the position of senior
vice president of business development.

Campione will lead the development, negotiation, and finalization of
partnership agreements and contracts with major companies. These deals will
help fund research and development programs leveraging Solazyme's work on
biofuels and industrial chemicals.

Campione has extensive experience monetizing technology across diverse
industries and geographies. Most recently he was general manager and vice
president of Symyx Technologies, Inc., a company providing high throughput
research and informatics technologies globally to the chemical, energy,
polymer, pharmaceutical, and electronics industries. At Symyx, he was
accountable for collaborative research, strategic alliances, and materials
licensing. During his tenure, Campione leveraged the company's technology
position to negotiate more than $400 million of new research services,
products, and licensing revenues with major chemical and energy companies
including ExxonMobil, Dow Chemical, BP, Ineos, Innovene, and Celanese.

"Troy's breadth of experience in developing strategic alliances along
with his talent for licensing technologies will enhance our ability to
develop relationships with potential partners as we commercialize our
algal-based technologies," said Jonathan Wolfson, president and chief
operating officer of Solazyme. "We are extremely excited to have him join
our management team."

Prior to Symyx, Campione spent 15 years at ExxonMobil in business,
research and development, and technology management positions in Houston,
Baytown, and Baton Rouge. He led the research and development activities
for advanced catalyst and process technologies as worldwide basic chemicals
technology manager, delivered continued success and growth of the vinyl
intermediates area as its business manager, and prioritized, championed,
and secured significant chemical plant expansions for the intermediates
business of Exxon Chemical.

Campione earned his Ph.D. in chemical engineering from the University
of Texas at Austin and also holds M.E. and B.S degrees in Chemical
Engineering from Tulane University.

About Solazyme:

Founded in 2003 and headquartered in South San Francisco, California,
Solazyme is a leading biotechnology company focused on the engineering and
optimization of algae for production of biofuels and health and wellness
materials. For more information, please visit our website:
http://www.solazyme.com.

(Date:12/8/2016)... Ames, Iowa (PRWEB) , ... December 08, 2016 , ... ... of asynchronous approvals for biotech crops. The authors focus on the economic effects in ... the global approval of new biotech crops and the resultant risk of low level ...

(Date:12/8/2016)... 8, 2016 Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... developing and commercializing products to treat rare diseases where ... it will be hosting an Investor Webcast Event Friday, ... origins of innate defense regulators (IDRs) as a new ... mucositis and the recently announced and published Phase 2 ...

(Date:11/21/2016)... 2016 Neurotechnology , a provider of ... announced that the MegaMatcher On Card fingerprint matching ... the NIST Minutiae Interoperability Exchange (MINEX) III ... steps of the evaluation protocol. ... of fingerprint templates used to establish compliance of ...

(Date:11/15/2016)... Md. , Nov. 15, 2016 Synthetic ... company developing therapeutics focused on the gut microbiome, ... offering of 25,000,000 shares of its common stock ... common stock at a price to the public ... proceeds to Synthetic Biologics from the offering, excluding ...

(Date:6/22/2016)... , June 22, 2016 The American College of ... Trade Show Executive Magazine as one of the fastest-growing ... May 25-27 at the Bellagio in Las Vegas ... the highest percentage of growth in each of the following ... exhibiting companies and number of attendees. The 2015 ACMG Annual ...